Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study.
Gristina V, Bazan V, Barraco N, Taverna S, Manno M, Raccosta S, Carreca AP, Bono M, Bazan Russo TD, Pepe F, Pisapia P, Incorvaia L, Badalamenti G, Troncone G, Malapelle U, Santini D, Russo A, Galvano A. Gristina V, et al. Among authors: troncone g. Mol Oncol. 2025 Jan 9. doi: 10.1002/1878-0261.13737. Online ahead of print. Mol Oncol. 2025. PMID: 39780749 Free article.
Liquid Biopsy and Lung Cancer.
Pisapia P, Malapelle U, Troncone G. Pisapia P, et al. Among authors: troncone g. Acta Cytol. 2019;63(6):489-496. doi: 10.1159/000492710. Epub 2018 Dec 19. Acta Cytol. 2019. PMID: 30566947 Review.
Predictive biomarkers for molecular pathology in lung cancer.
Pisapia P, Pepe F, Troncone G, Malapelle U. Pisapia P, et al. Among authors: troncone g. Biomark Med. 2020 Mar;14(4):253-257. doi: 10.2217/bmm-2019-0490. Epub 2020 Mar 3. Biomark Med. 2020. PMID: 32125183 No abstract available.
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials.
Galvano A, Gristina V, Malapelle U, Pisapia P, Pepe F, Barraco N, Castiglia M, Perez A, Rolfo C, Troncone G, Russo A, Bazan V. Galvano A, et al. Among authors: troncone g. ESMO Open. 2021 Jun;6(3):100124. doi: 10.1016/j.esmoop.2021.100124. Epub 2021 Apr 30. ESMO Open. 2021. PMID: 33940346 Free PMC article. Review.
394 results